iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Q1 FY23 Preview: Dr Reddy's: Revenue seen at Rs54,128 million; PAT at Rs6,790 million

27 Jul 2022 , 04:07 PM

Results Date: 28th July
Recommendation: Buy
Target price: Rs4,800

Source: IIFL Research

June 2022 quarter revenue of Dr Reddy’s is forecasted at Rs54,128 million. This will be a y-o-y growth of 10.8%. PAT is forecasted at Rs6,790 million. This will be a y-o-y growth of 19.8%. Demand for drugs in areas such as Dermatology and Nephrology are expected to be higher in the June quarter. 

Key management insights to look into:

  • Trends in raw material prices
  • Outlook on growth in generic drugs market in US
June 2022 estimates Y-o-Y
Revenue (Rs mn) 54,128 10.8%
PAT 6,790 19.8%

Source: Brokerage Reports

Related Tags

  • Dr Reddys
  • June 2022 quarter
  • Q1FY23
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.